Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft

European Journal of Pharmacology

Volumn 666, Issue 1-3, 2011, Pages 150-157

  Yaktubay Döndaş, Naciye ^a   Sucu, Nehir ^b   Coşkun Yilmaz, Banu ^b   Kaplan, Halil Mahir ^a   Özeren, Murat ^b   Karaca, Mehmet Kerem ^b   Vezir, Özden ^b   Şingirik, Ergin ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

Coronary artery bypass surgery; Human saphenous vein graft; Molecular mechanism; Statin

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN II; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOMETACIN; MEVALONOLACTONE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; PRAVASTATIN; PROSTAGLANDIN SYNTHASE; RHO KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; LIPID METABOLISM; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANGIOTENSIN II; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RHO-ASSOCIATED KINASES; SAPHENOUS VEIN; VASODILATION; VASODILATOR AGENTS;

EID: 79960026090     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.05.013     Document Type: Article

References (38)

1. Y. Birnbaum, Y. Ye, S. Rosanio, S. Tavackoli, Z.Y. Hu, E.R. Schwarz, and B.F. Uretsky Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury Cardiovasc. Res. 65 2005 345 355 (Pubitemid 40082476)
2. M. Chello, C. Spadaccio, A. Anselmi, G. Patti, M. Lusini, G. Di Sciascio, and E. Covino Simvastatin reduces CD40 expression in an experimental model of early arterialization of saphenous vein graft J. Surg. Res. 136 2006 302 308 (Pubitemid 44737844)
3. J.C. Chen, K.C. Huang, B. Wingerd, W.T. Wu, and W.W. Lin HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPbeta Exp. Cell. Res. 301 2004 305 319 (Pubitemid 39504982)
4. L.V. d'Uscio, S. Milstien, D. Richardson, L. Smith, and Z.S. Katusic Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity Circ. Res. 92 2003 88 95 (Pubitemid 36105611)
5. M.R. Dashwood, K. Savage, A. Dooley, X. Shi-Wen, D.J. Abraham, and D.S. Souza Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production Ann. Thorac. Surg. 80 2005 939 944 (Pubitemid 41196788)
6. F. Degraeve, M. Bolla, S. Blaie, C. Créminon, I. Quéré, P. Boquet, S. Lévy-Toledano, J. Bertoglio, and A. Habib Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins J. Biol. Chem. 14 2001 46849 46855
7. L.W. Dobrucki, L. Kalinowski, I.T. Dobrucki, and T. Malinski Statin-stimulated nitric oxide release from endothelium Med. Sci. Monit. 7 2001 622 627 (Pubitemid 32691737)
8. M. Endres, and U. Laufs Effects of statins on endothelium and signaling mechanisms Stroke 35 2004 2708 2711 (Pubitemid 39458376)
9. B. Gansera, F. Schmidtler, I. Angelis, T. Kiask, B.M. Kemkes, and F. Botzenhardt Patency of internal thoracic artery compared to vein grafts-postoperative angiographic findings in 1189 symptomatic patients in 12 years Thorac. Cardiovasc. Surg. 55 2007 412 417 (Pubitemid 350013792)
10. C.A. Hamilton, G. Berg, M. Mcintyre, A.R. Mcphaden, J.L. Reid, and A.F. Dominiczak Effects of nitric oxide and superoxide on relaxation in human artery and vein Atherosclerosis 133 1997 77 86 (Pubitemid 27322120)
11. K. Hinokiyama, G. Valen, S. Tokuno, J.B. Vedin, and J. Vaage Vein graft harvesting induces inflammation and impairs vessel reactivity Ann. Thorac. Surg. 82 2006 1458 1464 (Pubitemid 44402355)
12. I. Hubloue, B. Rondelet, F. Kerbaul, D. Biarent, G.M. Milani, M. Staroukine, P. Bergmann, R. Naeije, and M. Leeman Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs Crit. Care 8 4 2004 R163 R171
13. W.H. Kaesemeyer, R.B. Caldwell, J. Huang, and R.W. Caldwell Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions J. Am. Coll. Cardiol. 33 1999 234 241 (Pubitemid 29064099)
14. S. Kaplan, J.A. Morgan, G. Bisleri, F.H. Cheema, H.O. Akman, V.K. Topkara, and M.C. Oz Effects of resveratrol in storage solution on adhesion molecule expression and nitric oxide synthesis in vein grafts Ann. Thorac. Surg. 80 2005 1773 1778 (Pubitemid 41464299)
15. T. Kozai, M. Eto, Z. Yang, H. Shimokawa, and T.F. Lüscher Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway Cardiovasc. Res. 68 2005 475 482 (Pubitemid 41566567)
16. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 1998 1129 1135 (Pubitemid 28152885)
17. Z.G. Liu, X.C. Liu, A.P. Yim, and G.W. He Direct measurement of nitric oxide release from saphenous vein: abolishment by surgical preparation Ann. Thorac. Surg. 71 2001 133 137 (Pubitemid 32102647)
18. V.S. Mahadevan, M. Campbell, P.P. McKeown, and U. Bayraktutan Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity Cardiovasc. Res. 72 2006 60 68 (Pubitemid 44429903)
19. C.C. McGown, N.J. Brown, P.G. Hellewell, C.S. Reilly, and Z.L. Brookes Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III Br. J. Anaesth. 104 2010 183 190
20. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
21. M. Moreno, L.N. Ramalho, P. Sancho-Bru, M. Ruiz-Ortega, F. Ramalho, J.G. Abraldes, J. Colmenero, M. Dominguez, J. Egido, V. Arroyo, P. Ginès, and R. Bataller Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver Am. J. Physiol. Gastrointest. Liver. Physiol. 296 2009 G147 G156
22. K. Morikawa-Futamatsu, S. Adachi, Y. Maejima, M. Tamamori-Adachi, J. Suzuki, S. Kitajima, H. Ito, and M. Isobe HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1 Life Sci. 79 2006 1380 1390 (Pubitemid 44215930)
23. A. Nohria, A. Prsic, P.Y. Liu, R. Okamoto, M.A. Creager, A. Selwyn, J.K. Liao, and P. Ganz Statins inhibit Rho kinase activity in patients with atherosclerosis Atherosclerosis 205 2009 517 521
24. T. Nübel, W. Dippold, H. Kleinert, B. Kaina, and G. Fritz Lovastatin inhibits Rho-regulated expression of E-selectin by TNFα and attenuates tumor cell adhesion FASEB 18 2004 140 142
25. G. O'Driscoll, D. Green, and R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131 (Pubitemid 27097821)
26. Y. Rikitake, and J.K. Liao Rho GTPases, statins and nitric oxide Circ. Res. 97 2005 1232 1235
27. R. Rodrigues-Díez, C. Lavoz, S. Rayego-Mateos, E. Civantos, J. Rodríguez-Vita, S. Mezzano, A. Ortiz, J. Egido, and M. Ruiz-Ortega Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process PLoS One 5 2010 e14145
28. J.F. SabIk, B.W. Lytle, E.H. Blackstone, P.L. Houghtaling, and D.M. Cosgrove Comparison of saphenous vein and internal thoracic artery graft patency by coronary system Ann. Thorac. Surg. 79 2005 544 551 (Pubitemid 40186555)
29. J.H. Shuhaiber, A.N. Evans, M.G. Massad, and A.S. Geha Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery Eur. J. Cardiothorac. Surg. 22 2002 387 396 (Pubitemid 36157379)
30. V.S. Sottiurai, J.C. Stanley, and W.J. Fry Ultrastructure of human and transplanted canine veins: effects of different preparation media Surgery 93 1983 128 138
31. M. Takemoto, J. Sun, J. Hiroki, H. Shimokawa, and J.K. Liao Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase Circulation 106 2002 57 62 (Pubitemid 34747442)
32. J.C. Tsui, D.S. Souza, D. Filbey, M.G. Karlsson, and M.R. Dashwood Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel "no-touch" technique: potential role of nitric oxide contribution to improved early graft patency rates J. Vasc. Surg. 35 2002 356 362 (Pubitemid 44718645)
33. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol. Med. 14 2008 37 44
34. S. Wassmann, U. Laufs, A.T. Bäumer, K. Müller, K. Ahlbory, W. Linz, G. Itter, R. Rösen, M. Böhm, and G. Nickenig HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species Hypertension 37 2001 1450 1457 (Pubitemid 34225391)
35. 2-dependent relaxation in human internal mammary arteries: a comparative study with KDR and Flt-1 selective mutants J. Cardiovasc. Pharmacol. 44 2004 615 621 (Pubitemid 39441704)
36. A. Westerband, D. Crouse, L.C. Richter, M.L. Aguirre, C.C. Wixon, D.C. James, J.L. Mills, G.C. Hunter, and R.L. Heimark Vein adaptation to arterialization in an experimental model J. Vasc. Surg. 33 2001 561 569 (Pubitemid 32215607)
37. S. Wolfrum, K.S. Jensen, and J.K. Liao Endothelium-dependent effects of statins Arterioscler. Thromb. Vasc. Biol. 23 2003 729 736 (Pubitemid 36566160)
38. Y. Ye, S.P. Nishi, S. Manickavasagam, Y. Lin, M.H. Huang, J.R. Perez-Polo, B.F. Uretsky, and Y. Birnbaum Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2 Prostaglandins Other Lipid Mediat. 84 2007 43 53 (Pubitemid 47069933)